{"id":"https://openalex.org/W2603758718","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","title":"Linking kinases to adverse events through kinase inhibitors.","display_name":"Linking kinases to adverse events through kinase inhibitors.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2603758718","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","mag":"2603758718"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.e13524","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010342336","display_name":"Afsheen N. Iqbal","orcid":"https://orcid.org/0000-0003-4980-9954","observed_orcids":["https://orcid.org/0000-0003-4980-9954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Afsheen Iqbal","raw_affiliation_strings":["Mount Sinai Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Medical Center, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016960786","display_name":"Shan Zhao","orcid":"https://orcid.org/0000-0002-6618-8793","observed_orcids":["https://orcid.org/0000-0002-6618-8793"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan Zhao","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001938387","display_name":"Sonia Evelyn Reichert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonia Evelyn Reichert","raw_affiliation_strings":["Mount Sinai Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Medical Center, New York, NY","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert G. Maki","raw_affiliation_strings":["Mount Sinai School of Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai School of Medicine, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"e13524","last_page":"e13524"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.2515000104904175,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.2515000104904175,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.16099999845027924,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.15330000221729279,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7379999756813049},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6759999990463257},{"id":"https://openalex.org/keywords/kinase-specificity","display_name":"kinase specificity","score":0.8349999785423279},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4410000145435333},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.8650000095367432},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/asthenia","display_name":"asthenia","score":0.8930000066757202},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.8629999756813049},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9259999990463257},{"id":"https://openalex.org/keywords/braf-inhibition","display_name":"BRAF inhibition","score":0.8519999980926514},{"id":"https://openalex.org/keywords/vegfr1","display_name":"VEGFR1","score":0.7960000038146973},{"id":"https://openalex.org/keywords/fgfr3","display_name":"FGFR3","score":0.9160000085830688},{"id":"https://openalex.org/keywords/axl","display_name":"AXL","score":0.5770000219345093},{"id":"https://openalex.org/keywords/plk4","display_name":"PLK4","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tnik","display_name":"TNIK","score":0.722000002861023},{"id":"https://openalex.org/keywords/rps6ka1","display_name":"RPS6KA1","score":0.9539999961853027},{"id":"https://openalex.org/keywords/yes1","display_name":"YES1","score":0.9070000052452087},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.8401323556900024},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7965748310089111},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5992971062660217},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4541946053504944},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.44760650396347046},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.441056489944458},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.42560523748397827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41581615805625916},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41220685839653015},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2639085054397583},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13354191184043884},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12831762433052063},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1266251802444458},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.e13524","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.800000011920929,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4288051556","https://openalex.org/W2002083676","https://openalex.org/W4401412699","https://openalex.org/W2512385016","https://openalex.org/W2163094044","https://openalex.org/W3135139552","https://openalex.org/W7098015842","https://openalex.org/W1973763912","https://openalex.org/W4401418520","https://openalex.org/W3038122770"],"abstract_inverted_index":{"e13524":[0],"Background:":[1],"Small":[2],"molecule":[3],"oral":[4],"kinase":[5,76,99,109,122],"inhibitors":[6],"(SMOKIs)":[7],"are":[8,272],"anticancer":[9],"agents":[10],"with":[11,185,238,251,267],"unique":[12],"activity":[13],"and":[14,51,59,113,123,130,157,177,203,223,230,246,253,262,277,286],"toxicity.":[15],"We":[16,35,88,136],"sought":[17],"to":[18,29,46,84,104,179,274,292,315],"determine":[19],"if":[20],"specific":[21,30,293],"kinases":[22,306],"blocked":[23],"by":[24],"SMOKIs":[25,43,276,297],"could":[26],"be":[27,313],"linked":[28,291],"adverse":[31],"events":[32],"(AEs).":[33],"Methods:":[34],"identified":[36,307],"studies":[37,96],"in":[38,140,147],"which":[39],"cancer":[40],"indications":[41],"for":[42,62,117,120,149,153],"were":[44,70,234,249,265,288],"compared":[45,89],"placebo":[47],"or":[48],"other":[49],"therapy,":[50],"collected":[52],"prevalence":[53],"data":[54,74],"of":[55,67,92,100,126,132,162,182,188,302,320,323],"grade":[56],"3,":[57],"4,":[58],"5":[60],"AEs":[61,93,183,271,282],"each":[63,68,121,154],"study":[64,155],"arm.":[65],"Targets":[66],"SMOKI":[69,81],"screened":[71],"from":[72,94,308],"existing":[73],"on":[75],"specificity,":[77],"selecting":[78],"Kd<500nM.":[79],"Each":[80],"was":[82,102,110],"mapped":[83],"its":[85],"respective":[86],"kinases.":[87,280,294],"the":[90,98,108,115,124,138,145,160,163,180,300,317],"frequency":[91,106],"all":[95],"when":[97,107],"interest":[101,133,303],"involved":[103],"AE":[105,129,152],"not":[111,305],"involved,":[112],"computed":[114],"probabilities":[116],"attributed":[118],"risk":[119,214],"significance":[125,139,161],"association":[127],"between":[128],"drug":[131],"via":[134],"t-test.":[135],"evaluated":[137],"a":[141,150],"pair-wise":[142],"manner,":[143],"computing":[144],"difference":[146],"probability":[148],"single":[151],"independently,":[156],"then":[158],"evaluating":[159],"average":[164],"probability,":[165],"assuming":[166],"unequal":[167],"variance":[168],"across":[169],"studies.":[170],"Results:":[171],"67":[172],"trials":[173],"fit":[174],"our":[175],"criteria,":[176],"led":[178],"identification":[181],"associated":[184,237,250,266],"varying":[186],"number":[187],"kinases,":[189],"e.g.":[190],"diarrhea":[191,217],"(45":[192],"kinases),":[193,219],"asthenia":[194,287],"(43),":[195],"hypertension":[196],"(30),":[197,199],"rash":[198],"thrombocytopenia":[200],"(plts,":[201],"29),":[202],"neutropenia":[204,285],"(21).":[205],"Most":[206],"associations,":[207],"while":[208],"statistically":[209],"significant,":[210],"had":[211],"low":[212],"attributable":[213,228],"(\u22645%),":[215],"except":[216],"(24":[218],"hand-foot":[220],"syndrome":[221],"(19),":[222],"plts":[224],"(13).":[225],"BRAF":[226],"(5.4%":[227],"risk)":[229],"VEGFR1":[231],"(4.9%)":[232],"inhibition":[233],"most":[235],"strongly":[236],"hypertension;":[239],"AXL":[240],"(5.3%),":[241,243,257,259],"FGFR3":[242,263],"MAP4K5":[244],"(5%),":[245],"YES1":[247],"(5%)":[248,264],"neutropenia;":[252],"TNIK":[254],"(5.4%),":[255],"PLK4":[256],"STK16":[258],"RPS6KA1":[260],"(5.1%),":[261],"asthenia.":[268],"Conclusions:":[269],"Certain":[270],"common":[273],"many":[275,279],"thus":[278],"Other":[281],"such":[283],"as":[284],"more":[289],"tightly":[290],"By":[295],"developing":[296],"that":[298],"block":[299],"target":[301],"but":[304],"these":[309],"data,":[310],"it":[311],"may":[312],"possible":[314],"decrease":[316],"toxicity":[318],"burden":[319],"future":[321],"generations":[322],"SMOKIs.":[324]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-04-07T00:00:00"}